Innovative Science
Unlocking a Universe of
Therapeutic Breakthroughs

Through the Door

Sevion is a clinical stage therapeutics company which discovers and develops entirely new therapeutic classes for the treatment of cancer and immunological diseases. The Company’s product candidates are derived from multiple key proprietary technology platforms: cell-based arrayed antibody discovery, ultralong antibody scaffolds, eIF5A apoptotic regulatory systems, and chimerasome nanocages. Sevion has leveraged these technologies to build a pipeline of innovative proprietary and partnered product candidates.